[go: up one dir, main page]

HRP20080007T3 - Partikularni farmaceutski pripravak s produljenimotpuštanjem koji sadrži venlafaksin - Google Patents

Partikularni farmaceutski pripravak s produljenimotpuštanjem koji sadrži venlafaksin

Info

Publication number
HRP20080007T3
HRP20080007T3 HR20080007T HRP20080007T HRP20080007T3 HR P20080007 T3 HRP20080007 T3 HR P20080007T3 HR 20080007 T HR20080007 T HR 20080007T HR P20080007 T HRP20080007 T HR P20080007T HR P20080007 T3 HRP20080007 T3 HR P20080007T3
Authority
HR
Croatia
Prior art keywords
venlafaxine
preparation containing
pharmacological preparation
containing venlafaxine
release pharmacological
Prior art date
Application number
HR20080007T
Other languages
English (en)
Inventor
Pisek Robert
Zupancic Silvo
Mojca Segula Zakelj
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka filed Critical Krka
Publication of HRP20080007T3 publication Critical patent/HRP20080007T3/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Postupak dobivanja farmaceutskog pripravka koji sadrži venlafaksin ili njegovu farmaceutski prihvatljivu sol, koji se sastoji od slijedećih koraka: (1) dobivanja suspenzije venlafaksina ili soli venlafaksina u otapalu u kojem venlafaksin ili sol venlafaksina ima topivost manju od 25 g/l na sobnoj temperaturi; (2) prevođenja suspenzija iz koraka (1) u partikularni oblik; (3) oblaganja čestica dobivenih u koraku (2) slojem polimera za produljeno otpuštanje. Patent sadrži još 28 patentnih zahtjeva.
HR20080007T 2004-07-28 2005-07-27 Partikularni farmaceutski pripravak s produljenimotpuštanjem koji sadrži venlafaksin HRP20080007T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004036641A DE102004036641A1 (de) 2004-07-28 2004-07-28 Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
PCT/EP2005/008149 WO2006010605A2 (en) 2004-07-28 2005-07-27 Sustained release pharmaceutical particulate composition comprising venlafaxine

Publications (1)

Publication Number Publication Date
HRP20080007T3 true HRP20080007T3 (hr) 2008-01-31

Family

ID=35106687

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080007T HRP20080007T3 (hr) 2004-07-28 2005-07-27 Partikularni farmaceutski pripravak s produljenimotpuštanjem koji sadrži venlafaksin

Country Status (16)

Country Link
EP (1) EP1778193B1 (hr)
AT (1) ATE381925T1 (hr)
CY (1) CY1107187T1 (hr)
DE (2) DE102004036641A1 (hr)
DK (1) DK1778193T3 (hr)
EA (1) EA009957B1 (hr)
ES (1) ES2299061T3 (hr)
HR (1) HRP20080007T3 (hr)
NO (1) NO20071139L (hr)
PL (1) PL1778193T3 (hr)
PT (1) PT1778193E (hr)
RS (1) RS50572B (hr)
SI (1) SI1778193T1 (hr)
UA (1) UA83437C2 (hr)
WO (1) WO2006010605A2 (hr)
ZA (1) ZA200701554B (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
WO2003103637A2 (en) * 2002-01-10 2003-12-18 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
PL377473A1 (pl) * 2002-11-28 2006-02-06 Themis Laboratories Private Limited Sposób produkcji mikropeletek o przedłużonym uwalnianiu zawierających chlorowodorek wenlafaksyny

Also Published As

Publication number Publication date
DK1778193T3 (da) 2008-02-04
ZA200701554B (en) 2008-05-28
RS50572B (sr) 2010-05-07
EP1778193A2 (en) 2007-05-02
WO2006010605A3 (en) 2006-09-21
SI1778193T1 (sl) 2008-06-30
ES2299061T3 (es) 2008-05-16
CY1107187T1 (el) 2012-10-24
PT1778193E (pt) 2008-03-10
EA200700159A1 (ru) 2007-06-29
NO20071139L (no) 2007-02-28
EA009957B1 (ru) 2008-04-28
UA83437C2 (uk) 2008-07-10
ATE381925T1 (de) 2008-01-15
WO2006010605A2 (en) 2006-02-02
DE602005004033T2 (de) 2009-01-02
DE102004036641A1 (de) 2006-03-23
EP1778193B1 (en) 2007-12-26
DE602005004033D1 (de) 2008-02-07
PL1778193T3 (pl) 2008-05-30

Similar Documents

Publication Publication Date Title
HRP20150744T4 (hr) Modulatori farmakokinetičkih svojstava lijekova
JP2007302683A5 (hr)
WO2009024989A3 (en) A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
DK1906928T3 (da) Kerner og mikrokapsler egnet til parenteral administration og fremgangsmåder til fremstilling deraf
JP2010506699A5 (hr)
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
HRP20150056T1 (hr) Soli clopidogrela i postupak pripreme
FR2921835B1 (fr) Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables
NO20060428L (no) 2-amino-bicyklo[3.1.0]heksan-2,6-dikarboksylesterderivat
JP2009519849A5 (hr)
HRP20080007T3 (hr) Partikularni farmaceutski pripravak s produljenimotpuštanjem koji sadrži venlafaksin
SI2323634T1 (en) Ropinirole composition
JP2008521971A5 (hr)
JP2008519067A5 (hr)
ATE336230T1 (de) Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
JP2010518075A5 (hr)
EP2241571A4 (en) STABLE 6-METHOXY-2 ', 3'-DIDEOXYGUANOSINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREWITH
JP2007105705A5 (hr)
EP2233977A4 (en) COMPOSITION FOR FORMING A TOP ANTI-REFLEX FILM AND THE COMPOSITION USING THE STRUCTURE FORMATION PROCESS
HRP20090190T1 (hr) Farmaceutski pripravak koji sadrži sol mirtazapina
JP2004523567A5 (hr)
WO2008147169A8 (es) Microemolsion conteniendo pirfenidona
JP2004067614A5 (hr)
ATE446086T1 (de) Herstellung von lipid-beschichtetem cefuroxime axetil
ATE323698T1 (de) Neue 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinolin-4- one-derivate; verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten